Cystic Fibrosis Drug Could Help Treat Pneumonia
A cystic fibrosis drug proves effective, raising hope that it could be used to treat pneumonia regardless of the pathogen that caused it.
A cystic fibrosis drug proves effective, raising hope that it could be used to treat pneumonia regardless of the pathogen that caused it.
Even before the pandemic, an estimated 250,000-plus patients contracted VAP each year in the US, but effective strategies for infection control and ventilator management can reduce ventilator-associated pneumonia, as well as HAP and VAEs.
The US FDA has approved Pfizer's Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia in adults age 18 and older.
People who had bronchitis at least once before the age of seven are more likely to develop lung problems in later life, according to research presented at the virtual ERS 2020.
Read MoreA report from STAT News examines how the novel coronavirus pandemic can bring awareness to how providers diagnose other infections.
Read MoreThe FDA has approved Recarbrio (combination imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Read MoreElderly patients who are hospitalized with pneumonia are twice as likely to die as those hospitalized with hip fractures, yet many elderly people fail to accurately assess their risk of pneumonia, concludes research which will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Read MoreNew research, published in CHEST, questions using fever as an indicator for needing to take a blood culture in community-acquired pneumonia cases.
Read MoreAnti-MRSA therapy in addition to standard pneumonia therapy does not improve mortality rates in pneumonia patients, a study published in JAMA Internal Medicine found.
Read MoreThe United States Embassy in Beijing has announced that an American in Wuhan, China has died of coronavirus — the first reported death of a US citizen from the virus, CNN.com reports.
Read MoreRemoving the clock gene BMAL1 makes bacteria-engulfing defense cells in the body more effective, new research found.
Read MoreThe cause of several pneumonia cases in the Chinese city of Wuhan remains a mystery, as the number of infected people continues to grow, health authorities reported.
Read MoreA 34-year-old ESPN reporter is dead after battling pneumonia, according to several news reports.
Read MoreA team of molecular and structural biologists from Nanyang Technological University, Singapore (NTU Singapore) have found a potential new route to disabling respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) after elucidating the structure of one of its key components.
Read MoreThe US FDA has launched Cure ID, which will allow clinicians to report infectious disease treatments via a smartphone app.
Read More